Entering Yi Zhou

Hebei Yizhou Cancer Hospital is a tertiary cancer specialized hospital established with the approval of the Hebei Provincial Health Commission, integrating medical treatment, teaching, scientific research, prevention, and rehabilitation. The hospital is located at the 301 Guarantee Base in Wharf Town, Zhuozhou City, Hebei Province, adjacent to Beijing, with convenient transportation, beautiful environment, and complete facilities. In all aspects of hospital work, we always put patients at the center, adhering to the principle of "quality first, service first", and wholeheartedly provide high standard and high-quality medical services for every patient!

The hospital has a total investment of nearly 3 billion yuan, with an outpatient and inpatient building of over 200000 square meters and 1500 beds. There are now over 30 clinical and medical technology departments, including radiation therapy center, oncology comprehensive department, oncology internal medicine department, oncology surgery department, gynecology department, traditional Chinese medicine department, ICU department, anesthesia department, laboratory department, pharmacy department, radiology diagnosis department, ultrasound medicine department, pathology department, etc. The radiation therapy center includes head and neck tumor radiotherapy department (Radiotherapy Department 1), chest tumor radiotherapy department (Radiotherapy Department 2), abdominal tumor radiotherapy department (Radiotherapy Department 3) Pelvic Tumor Radiotherapy Department (Radiotherapy Department 5) and Child and Neurological Tumor Radiotherapy Department (Radiotherapy Department 6). The hospital is led by proton therapy, with radiation therapy as its characteristic, while also considering comprehensive tumor treatment such as surgery, chemotherapy, targeted therapy, immunology, and traditional Chinese medicine.

The hospital recruits talents and hires experts from well-known tertiary hospitals both domestically and internationally, including the People's Liberation Army General Hospital, Navy General Hospital, Air Force General Hospital, Rocket Army Hospital, Peking University First Hospital, and other hospitals. In addition, together with experts from MD Anderson in the United States and the Cancer Proton Therapy Center of the University of Pennsylvania, it forms a strong multidisciplinary tumor diagnosis and treatment (MDT) team to carry out advanced proton radiation therapy for tumors, To provide high-quality international and personalized medical services for cancer patients.

The radiation therapy center is located in Yizhou Tumor Hospital in Hebei Province, introducing the Belgian IBA Proteus PLUS proton therapy system, equipped with advanced CBCT image guidance system, respiratory gating technology, pen beam scanning technology, and a 360 ° rotating frame. The proton accelerator consists of 5 treatment rooms, including 4 rotating frame treatment rooms and 1 fixed beam treatment room; Four pen beam scanning treatment heads and one universal treatment head (with dual scattering and pen beam scanning functions) are currently one of the world's technologically advanced, fully functional, and large-scale proton therapy centers. At the same time, the hospital is also equipped with precision radiotherapy equipment such as 2 TOMO HD, 1 Versa HD, 1 VMAT linear accelerator, 1 ICON head gamma knife, 2 CT simulation positioning machines, and 1 MRI simulation positioning machine. It is also equipped with advanced imaging diagnosis and treatment equipment such as multiple CT, MRI, PET/CT, and ECT, providing patients with a "one-stop" medical service from examination, diagnosis to treatment.

Yizhou Cancer Hospital has conducted comprehensive and close cooperation with a series of units such as Peking University Cancer Hospital, Beijing Children's Hospital Affiliated to Capital Medical University, and the Department of Engineering Physics at Tsinghua University. We are committed to developing advanced tumor precision radiotherapy technology, creating a highland in the field of tumor proton therapy technology, and benefiting more tumor patients, especially children's tumor patients, both domestically and internationally.